Roberto Zatz

Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension.

Roberto Zatz, B R Dunn, Timothy W. Meyer et al. · Journal of Clinical Investigation · 1986 · 1.2K citations · Full text

Hypertension, Pharmacological Amelioration, Glomerulonephritis +21

Chronic inhibition of nitric oxide synthesis. A new model of arterial hypertension.

Miriam O. Ribeiro, Edson Antunes, Gilberto De Nucci et al. · Hypertension · 1992 · 791 citations · Full text

Hypertension, Renal Inflammation, Nephrology +18

Predominance of hemodynamic rather than metabolic factors in the pathogenesis of diabetic glomerulopathy.

Roberto Zatz, Timothy W. Meyer, Helmut G. Rennke et al. · Proceedings of the National Academy of Sciences · 1985 · 529 citations · Full text

Kidney Weight, Renal Pathology, Sham Treatment +23

Mycophenolate mofetil prevents the development of glomerular injury in experimental diabetes

Ricardo Utimura, Clarice Kazue Fujihara, Ana Lúcia Mattar et al. · Kidney International · 2003 · 200 citations · Full text

Metabolic Syndrome, Glomerulonephritis, Mycophenolate Mofetil +14

Effects of acute nitric oxide inhibition on rat glomerular microcirculation

Roberto Zatz, Gilberto De Nucci · American Journal of Physiology-Renal Physiology · 1991 · 187 citations

Endothelium-derived Relaxing Factor, Hypertension, Urology +13